eCART Clinical Deterioration

by AgileMD  · Based in United States → — Better Outcomes. Lower Clinical Burden. Stop working for your EHR. Make it work for you.
Anesthesiology Critical Care Hospital Medicine

Regulatory Status Disclosed

Overview

Predict & Prioritize Clinical Deterioration Early Warning & Workflow

AgileMD eCART™ is an FDA-cleared AI that guides care teams to the highest-risk patients using industry-leading AI combined with actionable, embedded decision support for all-cause clinical deterioration. It empowers nurses and providers with better information on patient status, more support with an acuity-based workflow, and significantly fewer false alarms. Developed from over a decade of research and clinical implementation, eCART was trained and tested on nearly 3 million patient encounters from 28 hospitals across 6 health systems, and retrospectively and prospectively validated on sepsis, COPD, CHF, and COVID populations.

Standardize & Improve Clinical Pathways

AgileMD also offers Clinical Pathways, providing highly-integrated and adaptable guidance to give care teams immediate access to the most updated protocols, streamlining order entry and documentation directly in their workflows. These pathways help reduce clinical variation, integrate seamlessly with native EHR workflows, and can be deployed quickly without heavy IT reliance. Over 4,800 AgileMD pathways are live, covering adult, pediatric, and neonate topics in ambulatory, emergency, inpatient, ICU, and women’s health settings.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Accurate and early risk stratification
  • Timely and appropriate escalation of care
  • Decreased mortality, length of stay, and direct variable costs
  • Real-time eCART score updates
  • Acuity-based workflow support
  • Reduced alarm fatigue
  • Seamless EHR integration
  • Rapid deployment (days to weeks)
  • Reporting & Benchmarking
  • Peer-Reviewed & Validated (85+ medical journal publications)

Use Cases

  • Predicting and prioritizing patients at risk of clinical deterioration (death or ICU transfer)
  • Guiding care teams to high-risk patients
  • Standardizing and improving clinical protocols and pathways
  • Reducing clinical variation in patient care
  • Streamlining order entry and documentation
  • Improving adherence to guideline best practices

What Physicians Need to Know

Evidence Base
eCART is an FDA-cleared AI-powered software as a medical device (SaMD) developed from over a decade of research at the University of Chicago. It has been evaluated in 80 peer-reviewed publications and received federal funding from the U.S. Department of Health & Human Services (HHS). The system utilizes a machine learning algorithm trained and tested on nearly 3 million patient encounters from 28 hospitals across 6 health systems, providing all-cause clinical deterioration prediction. It includes embedded clinical pathways to guide medical staff.
Clinical Validation Studies
FDA clearance was based on clinical performance data from nearly two million hospitalizations across 21 hospitals, including substantial prospective real-world data. The algorithm was developed and validated on nearly 3 million hospitalizations across 28 hospitals in six health systems, demonstrating consistent accuracy across demographics and medical conditions. Retrospective and prospective validation studies showed eCARTv5 had a high AUROC (0.834) for predicting clinical deterioration, outperforming other early warning scores. It accurately identified high-risk patients with conditions such as sepsis, heart failure, COPD, and COVID-19. Yale New Haven Health System reported a 13% relative reduction in overall mortality and significant improvements in sepsis outcomes post-implementation.
Alert Fatigue Management
eCART was designed to maximize early identification of at-risk patients while minimizing false alarms and decreasing clinician workload. It achieved 90% pathway screening compliance at Yale New Haven Health System without a single interruptive alert, contrasting with 87% of interruptive Epic Sepsis alerts being ignored. eCART's Positive Predictive Value (PPV) of 17.3% was significantly higher than other scores like NEWS (9.5%) and Epic's Deterioration Index (6.3%) at comparable sensitivities, leading to fewer false alarms.
Differential Diagnosis Support
The tool provides all-cause clinical deterioration prediction. Once a patient's risk is determined, the system offers guidance for next steps through more than 3,350 embedded clinical pathways, aiding in further evaluation and management.
Clinical Workflow Integration
eCART directly and seamlessly integrates into existing Electronic Health Record (EHR) workflows, leveraging up to 97 real-time variables such as labs, vital signs, and nursing assessments. It provides an acuity-based workflow and includes embedded clinical pathways to streamline order entry and documentation, designed to decrease clinician workload.
Decision Audit Trail
The system offers reporting and benchmarking capabilities, allowing hospital teams to evaluate their performance and establish more productive practice patterns.
Physician Tip

Physicians should leverage eCART's FDA-cleared, AI-driven early warning system for proactive identification of patients at risk of all-cause clinical deterioration. Utilize the embedded clinical pathways to streamline evaluation and management, ensuring adherence to evidence-based protocols and reducing clinical variation. Trust the system's high predictive value and low false alarm rate to focus interventions on truly at-risk patients, thereby reducing alert fatigue and optimizing workload. The seamless EHR integration means critical information and guidance are available directly within your workflow, empowering timely and confident care escalation.

eCART is designed for direct and seamless integration with Electronic Health Record (EHR) systems. It extracts and analyzes up to 97 real-time variables, including lab results, vital signs, and nursing assessments, to generate risk scores. The system also embeds clinical pathways directly into native EHR workflows, facilitating rapid deployment without extensive IT support.

Details

Category Triage & ER/ICU AI
Pricing Unknown
DeploymentCloud-based SaaS platform that integrates seamlessly with existing EHR systems. Rapid deployment at scale in days to weeks.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

AgileMD eCART Clinical Deterioration Suite has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA). It is an AI-driven software as a medical device (SaMD) that continuously assesses hospitalized patients' risk of impending death or ICU transfer, assisting medical staff in swift and accurate recognition of patients requiring increased medical attention.

Integrations
EHR Not specified
Specialties Anesthesiology, Critical Care, Hospital Medicine

What the Web Says

AgileMD's eCART Clinical Deterioration Suite is an AI-powered software designed to predict in-hospital clinical deterioration, including conditions like sepsis, heart failure, and COPD. It integrates with Electronic Health Record (EHR) systems, continuously monitoring up to 97 real-time variables to generate a risk score and guide clinical staff to appropriate pathways. The system has received FDA 510(k) marketing clearance and has been implemented in various hospitals, including Yale New Haven Health, where it has shown promising results in improving patient safety and reducing clinician workload.

Overall: Positive

Strengths

  • Early identification of at-risk patients, often hours before a critical event.
  • Minimizes false alarms compared to traditional early warning scores.
  • Decreases clinician workload by focusing attention on patients who most need it.
  • Demonstrated reduction in mortality rates, with notable gains in sepsis-related deaths.
  • Integrates directly into existing Electronic Health Record (EHR) systems.
  • Backed by extensive clinical performance data from nearly two million hospitalizations across multiple hospitals.

Limitations

  • One study indicated that incorporating nursing intuition (dichotomous stable/unstable) did not improve eCART's ability to detect clinical deterioration, suggesting a need for more nuanced measures of intuition.
  • eCART Lite, a version with fewer variables, performed more poorly when predicting mortality alone.
  • General early warning scores, while efficient at identifying septic patients, may not replace the need for frequent sepsis screening in high-risk patients.
  • While the technology is advanced, successful implementation heavily relies on building the right processes, structures, and teamwork around the tool.
  • Some older studies on real-time automated alerts for clinical deterioration did not show significant improvements in patient outcomes.

Based on reviews from: AgileMD earns FDA nod for eCART Clinical Deterioration Suite - Pharmaceutical Technology, AgileMD receives FDA clearance for eCART to predict in-hospital clinical deterioration across medical conditions - BioSpace, FDA clears Agilemd's AI-driven clinical deterioration tool | BioWorld, How Yale New Haven Health uses eCART to support clinicians and patients - Becker's Hospital Review | Healthcare News & Analysis, Born at UChicago, AgileMD Takes Strides to Expand Healthcare Tech with Recent FDA Nod - Polsky Center for Entrepreneurship and Innovation, AgileMD's eCART software receives FDA approval for clinical use - Medical Device Network, How to Vet Early Warning Scores - AgileMD, The Undeniable Link Between Sepsis and Clinical Deterioration - AgileMD, Machine Learning Monitoring for Clinical Deterioration u00b7 Info for Participants - Clinical Trials, Predicting Patient Deterioration: A Review of Tools in the Digital Hospital Setting - PMC, Assessing the Added Value of Nursing Judgement to eCART for Predicting Clinical Deterioration - UChicago Medicine, Early Warning Systems : r/IntensiveCare - Reddit, Early Warning Scores With and Without Artificial Intelligence - PMC - NIH

Last updated: 2026-07-22

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate eCART Clinical Deterioration

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Medical Device Network
AgileMD's eCART software receives FDA approval for clinical use - Medical Device Network
AgileMD's eCART Clinical Deterioration Suite, an AI-powered software as a medical device, received 510(k) marketing clearance from the FDA to continuously assess the risk of impending death or ICU transfer for hospitalized patients. The software integrates with EHR systems and uses up to 97 real-time variables to provide risk scores and guide clinical pathways.
2024-06
BioWorld
FDA clears Agilemd's AI-driven clinical deterioration tool | BioWorld
AgileMD Inc. secured FDA clearance for its eCART Clinical Deterioration Suite, an AI-powered software that utilizes a machine learning algorithm to continuously evaluate the risk of a hospitalized patient's death or transfer to intensive care based on 97 real-time variables. This tool aims to signal deterioration hours before critical illness becomes apparent, potentially saving lives and reducing morbidity.
2024-06
Business Wire
AgileMD receives FDA clearance for eCART to predict in-hospital clinical deterioration across medical conditions - Business Wire
AgileMD announced that the U.S. FDA has granted 510(k) marketing clearance for its eCART Clinical Deterioration Suite, an AI-driven software designed to continuously assess hospitalized patients' risk of impending death or ICU transfer. The clearance was based on clinical performance data from nearly two million hospitalizations across 21 hospitals.
2024-06
Medical Device Network
AgileMD earns FDA nod for eCART Clinical Deterioration Suite
AgileMD has obtained FDA 510(k) marketing clearance for its AI-powered eCART Clinical Deterioration Suite, which is designed to predict in-hospital clinical deterioration across various medical conditions. The software uses a machine learning algorithm to continuously monitor hospitalized patients and assess their risk of imminent death or ICU transfer.
2024-06
Medical Product Outsourcing
AgileMD Wins FDA Nod for eCart Clinical Deterioration Suite | Medical Product Outsourcing
AgileMD received U.S. FDA 510(k) clearance for its eCART Clinical Deterioration Suite, an AI-powered software as a medical device that uses a machine learning algorithm to continuously evaluate hospitalized patients' risk of impending death or ICU transfer. The software integrates into the EHR and leverages up to 97 variables to generate a risk score.
2024-06
University of Chicago Polsky Center
Born at UChicago, AgileMD Takes Strides to Expand Healthcare Tech with Recent FDA Nod
AgileMD, founded at the University of Chicago, announced that its eCART Clinical Deterioration Suite has received 510(k) marketing clearance from the FDA. This AI-powered software assesses patient status in hospitals, helping medical staff quickly identify those needing increased attention, and is the only FDA-cleared device of its kind to undergo independent multi-center real-world testing.
2024-06
24x7 Magazine
FDA OKs AgileMD eCART Clinical Deterioration Suite - 24x7
AgileMD's eCART Clinical Deterioration Suite has received FDA 510(k) marketing clearance, allowing it to assess hospitalized patients' risk of death or ICU transfer. The AI-powered software utilizes real-world clinical performance data to ensure accuracy across diverse patient demographics and medical conditions.
2024-07
Medgadget
Clinical Decision Support System Market Size 2026-2035
AgileMD's eCART Clinical Deterioration Suite received FDA 510(k) clearance in June 2024 for inpatient risk prediction covering sepsis, heart failure, and COPD. This clearance establishes a replicable regulatory template for other predictive Clinical Decision Support (CDS) vendors, potentially accelerating the commercialization of future AI-driven CDS tools.
2026-06

Videos

Product demos, reviews, and walkthroughs for eCART Clinical Deterioration.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

eCART is an AI-driven software as a medical device (SaMD) that integrates directly into the electronic health record (EHR) system. It continuously monitors up to 97 real-time variables, including vital signs, laboratory results, and nursing assessments, to calculate a patient's risk of clinical deterioration. This allows for continuous assessment and provides an interpretable patient dashboard with actionable clinical workflows to guide next steps in care.
eCART is designed to maximize early identification of at-risk patients, minimize false alarms, and decrease clinician workload by providing a streamlined approach to patient assessment. Studies have shown that eCART can identify signs of patient deterioration hours before a critical event, leading to improved patient safety and a reported 13% relative decrease in mortality in some health systems.
While eCART aims to reduce false alarms, a general challenge with clinical decision support tools can be alarm fatigue if not properly implemented or tuned. Additionally, the effectiveness of such tools is dependent on the quality and completeness of underlying EHR data, as suboptimal data entry can hinder the system's ability to generate appropriate interventions.
Yes, AgileMD's eCART Clinical Deterioration Suite has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA). This clearance was based on clinical performance data from nearly two million hospitalizations across 21 hospitals, demonstrating its accuracy in identifying high-risk patients across various conditions like sepsis, heart failure, and COPD.
Alternatives to eCART include traditional early warning scores such as the Modified Early Warning Score (MEWS) and the National Early Warning Score (NEWS), as well as other machine learning-based predictive analytics platforms. While these systems also aim to detect deterioration, eCART has demonstrated superior accuracy in identifying at-risk patients compared to many traditional scores.
Specific pricing details for eCART are not publicly disclosed, as is common for enterprise-level clinical decision support software. Generally, such systems are priced based on factors like the size of the healthcare institution, the number of beds, the scope of integration with existing EHR systems, and the specific modules or features implemented. Hospitals often evaluate these solutions based on their potential return on investment through improved patient outcomes and operational efficiencies.

Related Tools

KATE AI
Mednition
Clinical Decision Support & Reference
KATE AI is a nurse-built clinical decision support tool for emergency departments that analyzes incoming patients in real-time to flag high-risk cases that standard acuity scoring might miss. It has supported over 5,000,000 patient visits, helping emergency teams deliver safer, faster, and more informed care.
Sepsis Watch
Duke Health
Clinical Decision Support & Reference
Sepsis Watch is a deep learning alert system developed by Duke Health to identify and manage sepsis in real-time within ED and ICU settings. It has been associated with a significant reduction in sepsis deaths and improved compliance with treatment protocols.
CalmWave, Inc.
CalmWave, Inc.
Practice Analytics & BI
CalmWave is an AI-powered hospital operations platform designed to combat clinical alarm fatigue and improve patient safety and staff retention. It integrates real-time data from bedside monitors, other devices, alarms, and EHRs to provide actionable insights and reduce non-actionable alarms.
Bayesian Health Sepsis Flagging Device
Bayesian Health, Inc.
Clinical Decision Support & Reference
Bayesian Health's Sepsis Flagging Device is an AI clinical decision support system that monitors EHR data to provide early warnings for sepsis. It continuously monitors patient data across vitals, lab results, and clinical notes, identifying patterns that may indicate worsening conditions. The system puts out a flag, such as “sepsis risk high,” within the health record to help clinicians detect sepsis early.
Vascular Assist Occlusion Triage (VAOT)
GuideAI Health
Clinical Decision Support & Reference
Vascular Assist Occlusion Triage (VAOT) is an AI tool by GuideAI Health designed to assist radiologists in the rapid identification of vascular occlusions from medical images.
Savience Digital Triage
Savience Ltd
Patient Intake & Forms
Savience Digital Triage is a patient-centered, data-driven intake solution that optimizes every step of the triage journey, from arrival to clinical assessment, by allowing patients to self-stream via kiosks or mobile devices and feeding symptom and urgency questions directly into clinical workflows.

See all Triage & ER/ICU AI tools →

More from AgileMD

eCARTv5 Clinical Deterioration Suite (“eCART”)
AgileMD
Clinical Decision Support & Reference
AgileMD's eCARTv5 Clinical Deterioration Suite is an FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-21 | First Added: 2026-04-21
AI Tool Finder
AI-powered search. Results may not be comprehensive.